"The US Food and Drug Administration (FDA) has approved an expanded indication for onabotulinum toxin A (Botox, Actavis) for the treatment of adults with upper limb spasticity, according to a company news release.
The expanded i"...
(Generic versions may still be available.)
The recommended dosage of up to 0.30 mg/kg (approximately 0.90 IU/kg) of body weight weekly should not be exceeded due to the potential risk of known effects of excess human growth hormone.
Protropin® (somatrem for injection) should not be used in subjects with closed epiphyses.
Last reviewed on RxList: 12/8/2004
Additional Protropin Information
Report Problems to the Food and Drug Administration
Find out what women really need.